127 related articles for article (PubMed ID: 18201402)
1. Cervical screening: why young women should be encouraged to be screened.
Herbert A; Holdsworth G; Kubba AA
J Fam Plann Reprod Health Care; 2008 Jan; 34(1):21-5. PubMed ID: 18201402
[TBL] [Abstract][Full Text] [Related]
2. Invasive cervical cancer audit: why cancers developed in a high-risk population with an organised screening programme.
Herbert A; Anshu ; Culora G; Dunsmore H; Gupta SS; Holdsworth G; Kubba AA; McLean E; Sim J; Raju KS
BJOG; 2010 May; 117(6):736-45. PubMed ID: 20184570
[TBL] [Abstract][Full Text] [Related]
3. The use of screening episodes linked to CIN3 and invasive cancer registrations to study outcomes from the NHS Cervical Screening Programme.
Blanks RG; Moss SM; Coleman DA; Addou S; Swerdlow AJ
Cytopathology; 2009 Jun; 20(3):154-60. PubMed ID: 19207309
[TBL] [Abstract][Full Text] [Related]
4. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
[TBL] [Abstract][Full Text] [Related]
5. HPV testing compared with routine cytology in cervical screening: long-term follow-up of ARTISTIC RCT.
Gilham C; Sargent A; Kitchener HC; Peto J
Health Technol Assess; 2019 Jun; 23(28):1-44. PubMed ID: 31219027
[TBL] [Abstract][Full Text] [Related]
6. Cervical intraepithelial neoplasia grade III (CIN III) and invasive cervical carcinoma: the yawning gap revisited and the treatment of risk.
Herbert A; Smith JA
Cytopathology; 1999 Jun; 10(3):161-70. PubMed ID: 10390064
[TBL] [Abstract][Full Text] [Related]
7. Intensified screening among high risk women within the organised screening programme for cervical cancer in Finland.
Kotaniemi-Talonen L; Malila N; Anttila A; Nieminen P; Hakama M
Acta Oncol; 2011 Jan; 50(1):106-11. PubMed ID: 20560860
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial.
Rijkaart DC; Berkhof J; Rozendaal L; van Kemenade FJ; Bulkmans NW; Heideman DA; Kenter GG; Cuzick J; Snijders PJ; Meijer CJ
Lancet Oncol; 2012 Jan; 13(1):78-88. PubMed ID: 22177579
[TBL] [Abstract][Full Text] [Related]
9. Safety of extending screening intervals beyond five years in cervical screening programmes with testing for high risk human papillomavirus: 14 year follow-up of population based randomised cohort in the Netherlands.
Dijkstra MG; van Zummeren M; Rozendaal L; van Kemenade FJ; Helmerhorst TJ; Snijders PJ; Meijer CJ; Berkhof J
BMJ; 2016 Oct; 355():i4924. PubMed ID: 27702796
[TBL] [Abstract][Full Text] [Related]
10. How many cervical cancers are prevented by treatment of screen-detected disease in young women?
Sasieni P; Castanon A; Parkin DM
Int J Cancer; 2009 Jan; 124(2):461-4. PubMed ID: 18844220
[TBL] [Abstract][Full Text] [Related]
11. Invasive cervical cancer audit: a relative increase in interval cancers while coverage increased and incidence declined.
Herbert A; Anshu ; Gregory M; Gupta SS; Singh N
BJOG; 2009 May; 116(6):845-53. PubMed ID: 19432575
[TBL] [Abstract][Full Text] [Related]
12. Risks of cervical intraepithelial neoplasia grade 3 or invasive cancers in ASCUS women with different management: a population-based cohort study.
Tai YJ; Chen YY; Hsu HC; Chiang CJ; You SL; Chen CA; Cheng WF;
J Gynecol Oncol; 2018 Jul; 29(4):e55. PubMed ID: 29770625
[TBL] [Abstract][Full Text] [Related]
13. Dramatic increase in cervical cancer registrations in young women in 2009 in England unlikely to be due to the new policy not to screen women aged 20-24.
Sasieni P; Castanon A
J Med Screen; 2012 Sep; 19(3):127-32. PubMed ID: 23093730
[TBL] [Abstract][Full Text] [Related]
14. Rate of cervical cancer, severe intraepithelial neoplasia, and adenocarcinoma in situ in primary HPV DNA screening with cytology triage: randomised study within organised screening programme.
Anttila A; Kotaniemi-Talonen L; Leinonen M; Hakama M; Laurila P; Tarkkanen J; Malila N; Nieminen P
BMJ; 2010 Apr; 340():c1804. PubMed ID: 20423964
[TBL] [Abstract][Full Text] [Related]
15. High-grade squamous intraepithelial lesion in women aged <30 years has a prevalence pattern resembling low-grade squamous intraepithelial lesion.
Vale DB; Westin MC; Zeferino LC
Cancer Cytopathol; 2013 Oct; 121(10):576-81. PubMed ID: 23765869
[TBL] [Abstract][Full Text] [Related]
16. The development of the referral outcome diagram and an analysis of laboratory cancer detection rates in the English NHS cervical screening programme--is there an optimum level of detection of CIN 1 and CIN 2 lesions?
Blanks RG
Cytopathology; 2008 Aug; 19(4):244-53. PubMed ID: 18476989
[TBL] [Abstract][Full Text] [Related]
17. Rational care or rationing care? The case of cervical screening across the United Kingdom.
Flynn H; Lewis P
Health Policy; 2013 Oct; 112(3):197-201. PubMed ID: 23910733
[TBL] [Abstract][Full Text] [Related]
18. [Health technology assessment report: HPV DNA based primary screening for cervical cancer precursors].
Ronco G; Biggeri A; Confortini M; Naldoni C; Segnan N; Sideri M; Zappa M; Zorzi M; Calvia M; Accetta G; Giordano L; Cogo C; Carozzi F; Gillio Tos A; Arbyn M; Mejier CJ; Snijders PJ; Cuzick J; Giorgi Rossi P
Epidemiol Prev; 2012; 36(3-4 Suppl 1):e1-72. PubMed ID: 22828243
[TBL] [Abstract][Full Text] [Related]
19. Cervical screening in 20-24-year olds.
Rieck GC; Tristram A; Hauke A; Fielder H; Fiander AN
J Med Screen; 2006; 13(2):64-71; discussion 62-3. PubMed ID: 16792827
[TBL] [Abstract][Full Text] [Related]
20. Benefits and potential harms of human papillomavirus (HPV)-based cervical cancer screening: A real-world comparison of HPV testing versus cytology.
Thomsen LT; Kjaer SK; Munk C; Ørnskov D; Waldstrøm M
Acta Obstet Gynecol Scand; 2021 Mar; 100(3):394-402. PubMed ID: 33566361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
